News
Oxford Pharmascience - Update regarding OXPzeroTM Ibuprofen Programmes
RNS Number: 5321 E Oxford Pharmascience Group PLC 09 May 2017 Oxford Pharmascience Group plc. Oxford Pharmascience Group plc, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, provides the following update on its OXPzero TM Ibuprofen programmes, following its consideration of further FDA feedback..
RNS Number: 5321 E Oxford Pharmascience Group PLC 09 May 2017 Oxford Pharmascience Group plc. Oxford Pharmascience Group plc, the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, provides the following update on its OXPzero TM Ibuprofen programmes, following its consideration of further FDA feedback..